Divis Laboratories Ltd | DIVI - Gross Profit On Sales

Stock Price
6,427.00
Daily Change
-47.00 -0.73%
Monthly
3.86%
Yearly
17.28%
Q1 Forecast
6,171.47

Divis Laboratories Ltd reported INR16.59B in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Aurobindo Pharma INR 51.23B 1.76B Dec/2025
Avita Medical AUD 14.95M 1.18M Jun/2025
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Ionis Pharmaceuticals USD 195M 40M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Lupin INR 49.76B 704.6M Dec/2025
Moderna USD 226M 583M Dec/2025
Organon & Co USD 854M 3M Dec/2025
Revvity USD 421.66M 47.06M Dec/2025
Tectonic Therapeutic USD 0 0 Mar/2025
Tilray USD 67.63M 15.62M Mar/2025
Viatris USD 1.15B 223.6M Dec/2025
Xeris Pharmaceuticals USD 63.38M 3.74M Sep/2025